Inovio Pharmaceuticals
INO
#8897
Rank
$0.14 B
Marketcap
$2.07
Share price
2.48%
Change (1 day)
-50.36%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -$0.11 Billion USD

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are $0.18 Million USD. In 2024 the company made an earning of -$0.11 Billion USD, an increase over its 2023 earnings that were of -$0.14 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.11 Billion0.95%
2024 -$0.11 Billion-20.03%
2023 -$0.14 Billion-51.56%
2022 -$0.28 Billion-8.26%
2021 -$0.31 Billion95.4%
2020 -$0.16 Billion36.62%
2019 -$0.12 Billion20.19%
2018 -$93.91 Million10.94%
2017 -$84.65 Million9.59%
2016 -$77.24 Million118.9%
2015 -$35.29 Million-10.67%
2014 -$39.5 Million83.32%
2013 -$21.55 Million
2011 -$22.23 Million15.64%
2010 -$19.23 Million37.7%
2009 -$13.96 Million2.19%
2008 -$13.66 Million-14.09%
2007 -$15.9 Million19.12%
2006 -$13.35 Million9.62%
2005 -$12.18 Million5.77%
2004 -$11.52 Million73.08%
2003 -$6.66 Million12.75%
2002 -$5.9 Million
2000 -$8.93 Million53.93%
1999 -$5.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$11.85 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-$75.08 Million-30.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.41 B-15,289.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
$23.09 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$9.32 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
$9.88 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-$2.76 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA